NCT03814434

Brief Summary

This study evaluates clinical and radiographic parameters among riks factor groups in patients with periimplantitis. This study will also treat and evaluate the patients response before and after surgical treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 28, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 21, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 24, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2020

Completed
Last Updated

March 11, 2019

Status Verified

March 1, 2019

Enrollment Period

1.7 years

First QC Date

January 21, 2019

Last Update Submit

March 7, 2019

Conditions

Keywords

peri-implantitisinflammationTherapy

Outcome Measures

Primary Outcomes (1)

  • Radiographic Bone height Gain

    Radiographic Bone Height Gain Comparison to baseline 3 months after surgical treatment

    3 months

Secondary Outcomes (1)

  • Periimplant Pocket probing depth

    3 months

Study Arms (4)

Smokers with Periimplantitis group

EXPERIMENTAL

Heavy smokers patients with periimplantitis will be evaluated and will have their clinical, biological and radiographic data collected at baseline, after non-surgical and surgical treatment and after 3, 6 and 12 months.

Procedure: Non-Surgical treatmentProcedure: Surgical Treatment

Type 2 Diabetes with Periimplantitis group

EXPERIMENTAL

Patients diagnosed with Type 2 Diabetes with periimplantitis will be evaluated and will have their clinical, biological and radiographic data collected at baseline, after non-surgical and surgical treatment and after 3, 6 and 12 months.

Procedure: Non-Surgical treatmentProcedure: Surgical Treatment

Chronic Periodontitis with Periimplantitis group

EXPERIMENTAL

Patients diagnosed with Chronic Periodontitis and periimplantitis will be evaluated and will have their clinical, biological and radiographic data collected at baseline, after non-surgical and surgical treatment and after 3, 6 and 12 months.

Procedure: Non-Surgical treatmentProcedure: Surgical Treatment

Control with Periimplantitis group

EXPERIMENTAL

Systemically healthy patients with periimplantitis will be included in this group. Patients will be evaluated and will have their clinical, biological and radiographic data collected at baseline, after non-surgical and surgical treatment and after 3, 6 and 12 months.

Procedure: Non-Surgical treatmentProcedure: Surgical Treatment

Interventions

Implant and teeth surfaces decontamination through scaling and planning, Curettage, profilaxys and Oral Hygiene orientation

Chronic Periodontitis with Periimplantitis groupControl with Periimplantitis groupSmokers with Periimplantitis groupType 2 Diabetes with Periimplantitis group

Anaesthesia, Incision, curettage, Treatment of the contaminated implant surface, Irrigation with saline, Guided Bone Regeneration and suture

Chronic Periodontitis with Periimplantitis groupControl with Periimplantitis groupSmokers with Periimplantitis groupType 2 Diabetes with Periimplantitis group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Implants diagnosed with peri-implantitis with boné defects; Probing depth ≥ 4mm; Positive Bleeding on Probing and Suppuration score; Radiographic Bone Loss ≥ 3mm; Generalized Chronic Periodontitis (Armitage, 1999); Heavy Smokers (\> 10 cigarets per day); Type 2 Diabetes Mellitus tipo 2 (ADA, 2005) with HbA1c between 6.5% and 7.5%

You may not qualify if:

  • Complete Edentulism; Mucosal disease; Alcohol abuse; Systemic disease except type 2 Diabetes Mellitus, that might interfere in periimplantitis progression; Medication intake: anticoagulants, antineoplasics, contraceptives, bisphosphonates and antidepressives; Medication intake in the last 6 months: antibiotics; Medication intake in the last 3 months: antiinflammatories; Aggressive Periodontitis and Anaphylactic shock history; Periodontal treatment in the last 6 months before the baseline; Periodontal Pockets \> 7mm; Light Smokers (\< 10 cigarets/day); Implant Mobility.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculdade de Odontologia Universidade de Sao Paulo

São Paulo, São Paulo, Brazil

RECRUITING

MeSH Terms

Conditions

Peri-ImplantitisDiabetes Mellitus, Type 2Cigarette SmokingPeriodontal DiseasesInflammation

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesTobacco SmokingSmokingBehaviorTobacco UsePathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Luiz A Lima, phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Surgeon will not be aware of group being treated. Analyses of the data and statistics will not show explain what group has originated the data. Groups will be identified as A, B, C or D.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is not a randomized study. All patients will entered the study after being diagnosed with periimplantitis. Patients will be allocated to different groups according to their condition: Heavy Smokers, Type 2 Diabetes Mellitus, Chronic periodontitis and systemically healthy patients (control group).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 21, 2019

First Posted

January 24, 2019

Study Start

May 28, 2018

Primary Completion

January 28, 2020

Study Completion

January 28, 2020

Last Updated

March 11, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations